immunogenicity safety intradermal hepatitis vaccine BACKGROUND chief barriers use hepatitis vaccine high cost vaccine number small research trials adequate immune response cost tenth vaccine intradermal technique purpose study results clinical trial METHODS Vaccine recipients health care providers police officers firefighters Recipients mL plasma-derived hepatitis vaccine days Antibody response day seroconversion sample-to-negative S/N ratio equal local systemic side effects RESULTS Six sixteen individuals vaccination series seroconversion rate seroconversion years years mean S/N ratio range age Side effects local reactions CONCLUSIONS results use intradermal technique cost-effective alternative intramuscular route individuals years intradermal technique individuals titers seroconversion restricted availability plasma-derived vaccine study similar trials recombinant vaccine 